Selected Articles on Diabetes Prevention and the Evidence-Base for the National Diabetes Prevention Program

Please find a list of references below that are relevant to diabetes prevention including clinical trials demonstrating the efficacy of diabetes prevention as well as translational studies based upon the trials. These are not mean to be a comprehensive list of studies, but a list to help people explore some of the literature on diabetes prevention, specifically the US-based Nation Diabetes Prevention Program efforts. Click on the article title below to link to a PubMed page containing the article abstract and links to the journal.

Commentaries on Diabetes Prevention

Ackermann, R. (2012). “Research to Inform Policy in Diabetes Prevention: A Work in Progress.” American Journal of Preventive Medicine 43(2): 225-227.
Moulton, A.D., A.L. Albright, et al. (2013). “Law, Public Health, and the Diabetes Epidemic.” American Journal of Preventive Medicine 45(4):488-495.

Overview of Prediabetes – Pathology and Care

American Diabetes Association. (2013). “Standards of Medical Care in Diabetes-2013.” Diabetes Care 36(S1):S11-S66.
Nolan, C.J., Damm, P. and M. Prentki. (2011). “Type 2 Diabetes across Generations: From Pathophysiology to Prevention and Management” Lancet 378:169-181.
Tabák, A.G., C.Herder, et al. (2012). “Prediabetes: a High-Risk State for Diabetes Development.” Lancet 16:2279-2290.

DPP-like Trials in Other Countries

Review of Trials

Baker, M.K., Simpson, K. et al. (2010). “Behavioral strategies in diabetes prevention programs: A systematic review of randomized controlled trials.” Diabetes Research and Clinical Practice 91:1-12

Selected Articles from Da Qing Study (China)

Li, G., P. Zhang, et al. (2006). “The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20 year follow-up Study.” Lancet 2008(371):1783-1789.
Pan, X., G. Li, et al. (1997). “Effects of Diet and Exercise in Preventing NIDDM in People with Impaired Glucose Tolerance.” Diabetes Care 20(4):537-544.
Qiao, Q., and Z. Pang, et al. (2010) “A Large-Scale Diabetes Prevention Program in Real-Life Settings in Qingdao of China (2006-2012).” Primary Care Diabetes 4:99-103.

Selected Articles from Finnish Diabetes Prevention Study (Finland)

Lindstrom, J., A. Louheranta, et al. (2003). “The Finnish Diabetes Prevention Study (DPS): Lifestyle Intervention and 3-Year Results on Diet and Physical Activity.” Diabetes Care 26(12): 3230-3236.
Lindstrom, J., P. Parikka, et al. (2006). “Sustained Reduction in the Incidence of Type 2 Diabetes by Lifestyle Intervention: Follow-up of the Finnish Diabetes Prevention Study.” Lancet 368:1673-1679.
Saaristo, T., L. Moilanen, et al. (2010). “Lifestyle Intervention for Prevention of Type 2 Diabetes in Primary Health Care: One-Year Follow-Up of the Finnish Diabetes Prevention Program (FIN-D2D).” Diabetes Care 33(10):2146-2151.
Tuomilehto, J., J. Lindstrom, et al. (2001). “Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance: Results from a Randomized Clinical Trial.” The New England Journal of Medicine 344(18):1343-1350.
Uusitupa, M., M. Peltonen, et al. (2010). “Ten-Year Mortality and Cardiovascular Morbidity in the Finnish Diabetes Prevention Study- Secondary Analysis of the Randomized Trial.” PLoS One 4(5): e5656.

The DPP Trial and Translation

DPP Trial and Selected Secondary Analyses

Diabetes Prevention Program Research Group (1999) “The Diabetes Prevention Program: Description of Lifestyle Intervention.” Diabetes Care 25:2165-2171.
Diabetes Prevention Program Research Group (1999) “The Diabetes Prevention Program: Design and methods for a clinical trial in the prevention of type 2 diabetes.” Diabetes Care 22:623-634
Ratner, R., R. Goldberg, et al. (2005). “Impact of Intensive Lifestyle and Metformin Therapy on Cardiovascular Disease Risk Factors in the Diabetes Prevention Program.” Diabetes Care 28:888-894
Knowler, W.C., E. Barrett-Connor, et al. (2002). “Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin.” The New England Journal of Medicine 346(6):393-403.
Perreault, L., Pan, Q., et al. 2012. “Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Outcomes Study.” Lancet 379:2243-2251.
Ratner, R., Christophi, C.A., et al 2008. “Prevention of Diabetes in Women with a History of Gestational Diabetes: Effects of Metformin and Lifestyle Interventions.” Journal of Clinical Endocrinology and Metabolism 93:4774-4779.
Ratner R., and R. Goldberg, et al. (2009). “10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.” Lancet 374:1677-1686.

Translational/Implementation Studies

DEPLOY Study

Ackermann, R.T., Finch, E.A., et al. (2008). “Translating the Diabetes Prevention Program into the Community: The DEPLOY Pilot Study.” American Journal of Preventive Medicine 35(4):357-363.
Ackermann, R.T., E.A. Finch, et al. (2011). “Long-Term Effects of a Community-Based Lifestyle Intervention to Prevent Type 2 Diabetes: The DEPLOY extension pilot study.” Chronic Illness 7(4):279-290.
Lipscomb, E.R., E.A. Finch, et al. (2009). “Reduced 10-Year Risk of Coronary Heart Disease in Patients who Participated in a Community-Based Diabetes Prevention Program: the DEPLOY pilot study.” Diabetes Care 32(3):394-396.

Other Translation/Implementation Efforts

Amundson, H., M. Butcher, et al. (2009). “Translating the Diabetes Prevention Program Into Practice in the General Community: Findings From the Montana Cardiovascular Disease and Diabetes Prevention Program.” The Diabetes Educator 35:209-223.
Katula, J.A., M.Z. Vitolins, et al. (2013). “The Healthy Living Partnerships to Prevent Diabetes Study: 2-Year Outcomes of a Randomized Controlled Trial.” American Journal of Preventive Medicine 44(4S4):S324-S332.
Jiang, L., S. Manson, et al. (2013). “Translating the Diabetes Prevention Program Into American Indian and Alaska Native Communities.” Diabetes Care 36(7):2027-2034.
Ma, J., V. Yank, et al. (2012). “Translating the Diabetes Prevention Program Lifestyle Intervention for Weight Loss Into Primary Care.” JAMA Internal Medicine 173(2):113-121.
Mays, R. (2012). “I CAN Prevent Diabetes (Individuals and Communities Acting Now to Prevent Diabetes): Strategies to Help Prevent Type 2 Diabetes in Minnesota.” On the Cutting Edge 33(4):12-15.
Oldenburg, B., P. Absetz, et al. (2011). “The spread and uptake of diabetes prevention programs around the world: a case study from Finland and Australia.” Translational Behavioral Medicine 1:270-282.
Seidel, M.C., R.O. Powell, et al. (2008). “Translating the Diabetes Prevention Program Into an Urban Medically Underserved Community: A nonrandomized prospective intervention study.” Diabetes Care 31(4):684-689.
Vojta, D., T.B Koehler, et al. (2013). “A Coordinated National Model for Diabetes Prevention. Linking Health Systems to an Evidence-Based Community Program.” American Journal of Preventive Medicine 44(4S4):S301-S306.

The National Diabetes Prevention Program

Albright, A.L. and E.W. Gregg. (2013). “Preventing Type 2 Diabetes in Communities Across the U.S.: The National Diabetes Prevention Program.” American Journal of Preventive Medicine 44(S4):S346-S351.

Review Articles

Baker, M., K. Simpson, et al. (2011). “Behavioral Strategies in Diabetes Prevention Programs: A Systematic Review of Randomized Controlled Trials.” Diabetes Research and Clinical Practice 91:1-12.
Johnson, M., Jones, R., et al. (2012). “Can Diabetes Prevention Programmes be Translated Effectively into Real-World Settings and Still Deliver Improved Outcome? A Synthesis of Evidence.” Diabetic Medicine 30:3-15.
Laws, R., A. St. George, et al. (2012). “Diabetes Prevention Research: A Systematic Review of External Validity in Lifestyle Interventions.” American Journal of Preventive Medicine 43(2):205-214.

Formal Cost Analyses of DPP Trial and DPP-Based Programs (Only Actual Costs, No Papers on Modeled Costs)

Herman, W.H., M. Brandle, et al, (2003). “Costs Associated with the Primary Prevention of Type 2 Diabetes Mellitus in the Diabetes Prevention Program.” Diabetes Care 26(1):36-47.
Lawlor, M.S., C.S. Blackwell, et al. (2013). “Cost of a Group Translation of the Diabetes Prevention Program: Healthy Living Partnerships to Prevent Diabetes.” American Journal of Preventive Medicine 44(S4):S381-S389.